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Summary 
On 7 and 8 January 2016, the International Risk Governance Council (IRGC) organised an international 
public conference on Planned Adaptive Risk Regulation. The Scientific Committee was composed of 
professors Granger Morgan (Carnegie Mellon University), Kenneth Oye (Massachusetts Institute of 
Technology), Arthur Petersen (University College London) and Jonathan Wiener (Duke University). The 
conference was hosted and co-organised by the Department of Science, Technology, Engineering and 
Public Policy at University College London (UCL STEaPP). 
The conference convened participants from academia, regulatory agencies and industry to discuss 
experiences, challenges and ways to improve regulation related to new scientific developments, 
emerging technologies and changing risks. Speakers compared and contrasted past and current cases 
and potential for planned adaptive regulation in the fields of air quality, pharmaceuticals, fuel 
economy standards, hydraulic fracturing, flood risk governance, autonomous vehicles, synthetic 
biology and precision medicine.  
The purpose of this conference was to discuss two main questions: 
• How can law and regulation keep up with advances in science and technology? 
Regulation of risk in sectors marked by rapid advances in science and technology needs to rely on 
projections of risks, benefits, safety, efficacy, and acceptable quality, with updates and revisions as 
new knowledge becomes available. Where context conditions change rapidly, a continuous re-
evaluation of risk is often needed. This calls for flexible and adaptive risk regulation. Static or rigid 
regulation, with just a one-time decision, may lead to gaps in risk management, as well as 
technological lock-ins, which can be a serious impediment to innovation. Regulatory initiatives to 
foster innovation while improving the use of pre-market and post-market information are now of 
increasing interest to regulators, industry and NGOs alike. Some current efforts, such as in 
pharmaceuticals, are focused on developing more adaptive approaches to the management of risks 
and uncertainty, through stages of sequential learning and decision making throughout the 
regulatory process. This conference looked at several case studies (noted above), and sought to 
identify different mechanisms or types of planned adaptive regulation that could be employed in 
future cases. 
• How can regulated parties cope with flexibility and adaptability in regulatory frameworks? 
In fields of new technologies, it is essential to address potential emerging risks without discouraging 
healthy risk taking and stifling innovative activities. Adaptive regulation may be needed to keep up 
with changing science and technology. At the same time, regulatory stability can encourage 
investment, whereas the prospect of revisions in regulatory and licencing frameworks can engender 
instability that inhibits investment. Thus, both adaptability and predictability are somehow needed. 
This calls for not just adaptability, but planned adaptive regulation – planning the adaptive 
character of regulation in advance. This conference studied and debated different ways to do this, 
including, for example, by involving the regulated parties in targeted government-sponsored 
research into emerging risks, which may lead to cutting-edge knowledge becoming available and 
less surprise about regulatory decision-making, but also requires ways to guarantee the 
independence and credibility of the research. 
This report was written by the IRGC secretariat, with contributions from doctoral students Daniel L 
Ribeiro1 and Michael Veale2, and the organizing committee. It summarizes each session and contains 
a short introduction to the concept of Planned Adaptive Regulation in the appendix. The detailed 
agenda and slide presentations are available from www.irgc.org.  
                                                     
1 Duke University School of Law, Duke University 
2 Department of Science, Technology, Engineering and Public Policy (UCL STEaPP), University College London 
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Conference Day 1 
What Is Planned Adaptive Regulation? 
How can regulation keep up with the pace of scientific, technological and societal developments? 
Taking this ‘pacing problem’ as the starting point, the first session introduced the purpose, objective 
and characteristics of Planned Adaptive Risk Regulation.3 Adaptive approaches aim to address the 
uncertainty, ambiguity and sometimes controversy that often characterise both scientific and 
technological developments on which policies and regulation need to rely, and changing context 
conditions, including those concerning social values and opinions. 
Arthur Petersen (UCL) presented a number of important questions that surround the theme of planned 
adaptive regulation (PAR). PAR is closely connected to the notion of deep uncertainties about risks – 
when there is not enough evidence to characterize the risks in traditional ways. Some examples 
relevant to PAR and that will be discussed in the conference are flood risks, autonomous cars, and 
precision medicine. However, PAR also involves thinking about uncertainty at a deeper methodological 
level, thus demanding a multifaceted investigation about how to deal with these types of risks. 
Following Lawrence McCray (MIT), PAR can be regarded as a policy tool that includes in the regulation 
a plan for a future review and revision, i.e., a reassessment of the knowledge base, leading to a new 
decision to keep or adjust the regulatory intervention. It also includes a planned targeted research 
effort to deal with knowledge gaps, which may even increase uncertainties, yet will improve our 
characterisation of them in the process. It suggests an overarching research agenda, touching different 
disciplines and areas, such as education, political science, and others.  
Considerations in the design of adaptive policies 
Changing circumstances can undermine how policies remain justified. In his overview talk Granger 
Morgan (CMU) identified and discussed several strategies that warrant consideration, including: 
1) The use of policy experiments to identify promising policy options and “red teams” to identify 
ways in which proposed regulatory strategies might be gamed by regulated entities before 
they are implemented, so that problems can be found and corrected while that is still easy to 
do.  
There is a risk that once a policy is in place, interest and stakeholder groups may develop, 
reopen political agreements, and this can substantially complicate subsequent revisions. One 
strategy to deal with this is to try to treat policies as experiments, learn as outcomes evolve, 
and design the initial policy to allow for adaptation in the face of learning and changed 
circumstances.  
Manski (20134) makes a case for adopting a diversity of policies (e.g., different plausibly good 
treatments for different populations). Such diversification strategies, especially if they are 
well-documented and the consequences are well-monitored, are especially feasible in a 
federal system such as the US in which 50 different states can serve as laboratories for policy 
                                                     
3 See Lawrence E. McCray, Kenneth A. Oye and Arthur C. Petersen (2010), “Planned adaptation in risk regulation: An initial 
survey of US environmental, health, and safety regulation”, in Technological Forecasting & Social Change 77: 951–959, 
available from http://www.sciencedirect.com/science/article/pii/S0040162509001942 ; Gary E. Marchant, Braden R. 
Allenby and Joseph R. Herkert (eds.) (2011), The Growing Gap Between Emerging Technologies and Legal-Ethical Oversight: 
The Pacing Problem (Springer). 
4 C. F. Manski, Public Policy in an Uncertain World , Harvard University Press (2013). 
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assessment or across the EU in which the possibility exists for 28 different member states to 
work to achieve the same general objective through the adoption of different strategies. 
2) Periodic mandatory regulatory review (including the need to differentiate general rules from 
specific applications), to make policies work as a ‘closed loop’, with feedback from 
implementation to provide corrective adjustments. Perhaps the best example of a mandatory 
review is the requirement under the US Clean Air Act that the national ambient air quality 
standards (NAAQS) for all of the major “criteria air pollutants” must be periodically revisited 
and considered for revision by the US Environmental Protection Agency (EPA). Over the years 
the implementation of this process has undergone various revisions, but it has always involved 
a detailed review by EPA staff of all relevant refereed literature, and a subsequent peer review 
by an independent “Clean Air Science Advisory Committee” (CASAC). 
3) The use of sunset rules, to avoid lock-in and ensure that rules become less onerous as 
knowledge improves. One powerful tool that legislators and agencies can use to assure that 
regulations and other policies do not become outmoded is to specify a “sunset” date at which 
a regulation or piece of enabling legislation terminates unless it is revisited and renewed. For 
example, in the US this strategy has been used to impose a periodic review of tax breaks for a 
variety of activities such for estate taxes and construction of wind and solar power plants. 
Where it is clear that there are knowledge gaps, the role of sunset clauses and breakpoints 
becomes important to force reconsideration. A push to conduct research is also needed – and 
this is often the weaker part of the ‘adaptive’ systems we see today, even in the already 
mentioned case of the US EPA dealing with air quality standards. 
While there is a strong case to be made that policies should be adaptive and should change as we learn 
more about physical processes and the behaviour of regulated entities, designing such policies can 
thus pose a variety of challenges.  
Morgan discussed two examples to clarify these points. The first, Carbon Capture and Sequestration, 
shows how industry can react against adaptive regulation when it is communicated poorly, if industry 
believes it challenges the stability needed for business planning. The second, the case of metallic out 
of manufacturing (using 3-D printing), involves the risk of prematurely freezing a regulatory approach. 
In the earlier technology of casting the metal parts, regulators adopted required the addition of extra 
metal to address uncertainty. Now that casting is well understood, such ‘casting factors’ are no longer 
needed, yet they remain in place. If a similar approach were adopted for metalic additive 
manufacturing, many of the benefits of this new technology would be obviated. 
Adaptive approaches that treat policies as experiments, thus enabling both adaptation and learning by 
design – via a diverse set of policy approaches – is interesting but will probably be challenging in 
implementation. 
A broader discussion about the institutional separation of researchers acting as ‘assessors’ and 
‘reviewers’ from those acting as ‘decision-makers’ is needed to advance the implementation of PAR. 
The lack of publication of negative results is also an issue that is often raised as slowing the use of 
scientific progress to improve risk management. 
What happens if regulation is not adaptive? 
Anne Glover (Aberdeen University) discussed EU regulatory policy, designed to incorporate evidence, 
as scientific input, at each stage of the policy cycle. Developing regulation at the European level tends 
to be a linear process involving broad consultation and extensive impact assessment. Evidence from 
science and technology informs the political and decision process but does not necessarily dictate the 
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outcome as many other factors are considered. It also often happens that the evidence underpinning 
the policy is not certain and may be continually evolving, especially in areas of new technology. The 
challenge then is to develop an evidence-based process where uncertainty can be included in policy 
formation in a way that does not reduce the confidence of business who may wish to invest in novel 
technology. To support business investment in new technology, regulation needs to be clearly defined. 
Glover urged that the initial definition of indicators for measuring policy achievement and the post-
implementation evaluation phase are steps of fundamental importance to the idea of adaptive 
regulation. One explanatory factor for the challenge of consensus-building during these and other 
steps is the mismatch between how politicians and scientists accept and welcome uncertainty. 
Evidence is not value-free, and on its own cannot dictate what to do. Especially when lives are involved, 
value systems cannot accept a hard calculus of risk, cost and benefit. The interplay and succession of 
several political institutions in the course of the policy process poses yet another roadblock. If PAR is 
to become a reality, policymakers and researchers need to be more clear about uncertainty and to 
guard against the exacerbation of public’s perception to some risks by traditional or social media. 
Biofuels regulation in the EU is a cautionary tale of how the policy cycle might work badly, given the 
lack of or slow adaptation in the face of unintended consequences. Conversely, a potential successful 
example is the adaptive pathways approach by the European Medicines Agency (EMA), where approval 
is granted in stages, and new data is generated throughout the process. This does not change the 
standards for evaluation of benefits and risks of medicine but facilitates progressive licensing, with full 
assessment eventually informed by earlier involvement of patients and larger sets of data. 
The discussion emphasised that some legal systems and the cultures that support them are more 
favourable than others to planned adaptation. For example, British traffic laws include the general 
standard to ‘cycle without due care’, which can be interpreted over time as culture and technology 
changes. This is in contrast to the high level of detail included in the US legal system for cycling and 
traffic safety, which may impose more specific requirements than in the UK. 
 
Adaptive Regulation: An Overview of Past and Current Experiences 
This session reviewed examples of current regulations in which planned adaptation is built in, such as 
in US and EU air quality regulation, or in transportation, and discussed where planned adaptation could 
be included, such as in hydraulic fracturing. Past successes and failures were discussed to address the 
challenges of designing and implementing planned adaptive regulation. 
Fuel-economy and carbon standards for motor vehicles 
As an illustration of planned adaptive regulation, John Graham (Indiana University) explored the 
forthcoming 2017 "mid-term review" of the US fuel economy standards for 2022–2025, and how 
those standards may need to be adapted to the new environment of low oil prices, much lower than 
was anticipated when the 2025 targets were set in 2012.  
In 2012 the US federal government established ambitious regulatory targets for average passenger-
vehicle fuel economy from 2016 through 2025. Those targets are seen as critical to both national 
climate and energy-security policies. However, the regulation of fuel-efficiency standards for motor 
vehicles was also introduced with the goal of offsetting the economic impact of increasing fuel prices 
on consumers. From 2012 to 2016, there were significant changes in the fuel prices, affecting the initial 
rationale for the regulatory intervention. The initial cost–benefit justification of the program is at risk. 
Consequently, the upcoming review of the fuel standards might prove politically difficult. This question 
 
Planning Adaptive Risk Regulation Conference Report  //  8 
promises to be a prominent example of how policy adaptation requires openness to changing 
economic conditions and politics.  
Scientific and technological change is an idea at the forefront of the current debate on PAR. However 
economics and politics should also be considered as key changing factors suggesting or even requiring 
policy adaptation. 
Planned adaptation in retrospect: Lessons from exemplary cases and cautionary tales 
Under conditions of uncertainty and complexity, the need for adaptive strategies of risk management 
is manifest. Yet the design and implementation of effective systems of planned adaptation is 
difficult. The presentation from Kenneth Oye (MIT) looked back at examples of successful and 
unsuccessful adaptive policy systems. 
Exemplary cases include: 
• The policies resulting from the 1953 flood disaster in the Netherlands and from the 1995 Kobe 
earthquake 
• EU Transmissible Spongiform Encephalopathies (TSE) Programme to manage and prevent an 
epidemic of mad cow disease, Bovine Spongiform Encephalopathy (BSE) 
• The institutional reforms in the US aviation safety area post 1975, with the US National 
Transportation Safety Board 
• The US National Ambient Air Quality Standards (NAAQs) for fine particulate matter (PM 2.5) 
• The recent approach to adaptive licensing of pharmaceuticals, designed to systematically 
explore uncertainty, thus generating information and feedback into the program. In interesting 
ways, adaptive licensing represents a sophisticated example of PAR. On the front end, it 
includes earlier and conditional approval to particular patients, who benefit the most and 
contribute to evidence development. On the back end, it strengthens observation and 
modification to labels and licenses. The EMA Adaptive Pathways approach is itself an 
experiment. 
Cautionary tales of unsuccessful past nominally adaptive policy systems include: 
• The Thalidomide, Accutane and Vioxx crises 
• Lack of early access to HIV/Cancer treatments 
• Lack of institutional reform and implementation of PAR by the US NASA after the 1986 Space 
Shuttle Challenge disaster 
• Delay in the translation of research results on harmful effects of transfat into regulatory 
measures. 
• The lack of adaptive regulation around pensions and life expectancy was also raised. 
Historically, crisis events have prompted regulatory changes. Sometimes, such changes led to the 
implementation of PAR systems; other times, the reaction either was restricted to piecemeal 
modifications, took too long, or simply failed to improve the regulation based on lessons from the 
crisis.  
According to Kenneth Oye, elementary principles for governing emerging risks include: 
• Prospectively planned adaptation: as both phenomena being regulated and effects of 
regulatory policies are not well understood upfront, it is key to understand change with 
empirical observations. Policies should be proactive and adaptive, engaging with priors on risks 
and benefits, and updating as understandings of risks and benefits evolve. 
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• Observing, sensing, and revealing: because parties differ in their interest in harvesting and 
sharing information needed to evaluate benefits/risks, policies should create incentives and 
cut disincentives to reveal information needed for risk management (research funding, liability 
and intellectual property law). 
• Credible knowledge assessment: because conflicts of interest, organisational inertia and prior 
beliefs typically create bias in observation and assessment, policies should provide for credible 
and legitimate assessment of scientific and technical information under complexity, 
uncertainty and controversy.  
Oye suggested that adaptive policies are influenced by limiting factors: 
On the side of industries: 
• Industry incumbents prefer existing regulations, which define an environment that has been 
selective for these existing firms 
• Firms dislike policy variability and like predictability 
• Firms are concerned that regulatory variability would ratchet up and not down. 
On the side of regulators: 
• Regulators usually prefer to stick with existing hard-won regulations and standards 
• Regulators do not wish to risk de-legitimating rationales for existing policies 
• Regulators are concerned that variability will be seen as arbitrary and increase demand for 
deregulation. 
Among the public:  
• Limited public capacity and lack of interest in regulatory improvement poses a challenge for 
public authorities to acknowledge uncertainty, to be seen as possibly shifting targets or 
changing rationales. Regulators often need clearly defined trigger events to spur reforms that 
the public will accept.  
In the face of these limiting factors, Oye argued, assessing and adapting the role of the US National 
Academies, think tanks, universities, and some niche oriented firms will be needed to promote interest 
in more efficient and effective adaptive regulation of risks that would for example overcome the 
problem of free riding and the neglect of public goods. Good framing and communication will be 
crucial. 
Is adaptive risk regulation possible in a contentious political environment? The case of shale gas 
regulation in the EU  
Hydraulic fracturing for the production of shale gas in Europe (‘fracking’) is a particularly challenging 
case for implementing adaptive risk regulation. David Reiner (University of Cambridge) explained that 
the failure to develop shale gas in Europe is perhaps in part linked to the non-consideration of adaptive 
strategies. Any planned approach presumes at least some degree of social license to operate that 
would allow contingent regulation or even stakeholder engagement to be considered. Instead, even 
pilot projects or exploration wells are rebuffed out of fears that it will have a “camel’s nose” effect.  
In countries that have banned fracking (or instituted a moratorium), such as France, Germany or 
Bulgaria, there is little room for flexibility or creative approaches. In the few European countries that 
have strong government support, notably the UK and Poland, there have been early efforts at 
regulatory design, which have tried to include elements of compensation and public engagement. The 
success of both systems has been mixed at best.  
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Poland has, by far, the highest level of public support for fracking in the EU and has now gone through 
two rounds of regulation. The second round of regulation has tried to respond to perceived 
governance failures by offering firms a favourable system, but one which reduces the potential for 
stakeholder involvement.  
In the UK, unyielding government support for the nascent industry has led to minimal willingness to 
engage the public in a constructive fashion and derisory compensation offers. A ‘bad luck’ event with 
the first exploratory well in Lancashire contributed to intensifying the public’s risk perception of 
fracking, which translated into a moratorium and rejection of additional proposed wells. 
PAR of fracking in the EU has failed to take hold. A limited number of exploration wells in few European 
countries with higher levels of political acceptance of fracking has been generating little information 
necessary to enable learning. Miscommunication about risk and potentials, politicisation of the issue, 
lack of effective (and authentic) consultation strategies, and of building credibility in government 
institutions before authorising new activities with new risks may have undermined the potential for 
what could be (or have been) another relevant experiment of adaptive regulation. 
In the US, the states that have declared fracking as a ‘new technology’ have not done it, and those that 
have extended existing regulations have tended to engage in it. 
 
Adaptive Management of Natural Hazards  
This session looked at flood risk management, water quality standards, hurricanes modeling and 
insurance and decision making in the face of uncertainty. 
Many factors influence the risk and impact of natural hazards. Besides physical factors (e.g., landscape 
design, climate change), socio-economic factors (e.g., population, assets) are also important. Given 
that these factors change and feature complex and uncertain behaviour, the design and regulation of 
infrastructure and spatial developments will have to be flexible enough to be able to deal with such 
changes. 
Major questions to be tackled are: (i) how to deal with surprises in the knowledge base?, and (ii) how 
to manage stakeholder perceptions and participation in Planned Adaptive Risk Regulation practices? 
Adaptiveness in the Dutch Delta Programme 
Pieter Bloemen (Staff Delta Commissioner) presented the Dutch Delta Programme and the new (2014) 
Delta Plan (the nation’s second, more than 50 years after the first one), which explicitly includes 
‘Adaptive Delta Management’ as an integral part. The concept that underlies Adaptive Delta 
Management is the choice of strategies and measures that can give flexibility to respond to new 
knowledge, by stepping up efforts if necessary or changing strategy. 
Adaptiveness requires freedom of movement, tailored agility, and informed alertness: 
• Freedom of movement implies that there are options to choose from, both in the short and 
long term 
• Tailored agility demands decision-making processes that target the appropriate scales of 
action in time and in space. Anticipating predictable trends needs other processes than 
reacting to unexpected events. And updating nationwide safety standards needs other 
processes than rescheduling local implementation programmes 
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• Informed alertness requires both an open attitude to changing conditions and a coherent 
system for monitoring and evaluating developments. 
The Delta Programme on safety against flooding and on fresh water supply has followed this approach 
in its Adaptive Delta Management, which works as an adaptive management policy tool for flood safety 
and freshwater supply in the Netherlands. The method connects short-term decisions in the broad 
physical domain (land use planning, water management, housing, shipping, nature, recreation, etc.) 
with long-term tasks in the specific domains of safety against flooding and freshwater supply, while 
working with multiple ‘adaptation pathways’. In these ‘adaptation pathways’, decisions are made 
based on scenarios that take into account dynamic factors, such as how rapidly climate change 
develops. Analysis and decisions address which long-term options and intermediate steps must be left 
open, preparing for future transformations in the system, allowing freedom of movement. 
Preparations for implementing long-term options (e.g., preparing work on a levee) start as soon as a 
predefined ‘signal standard’ is reached, as revealed by the monitoring system in place. Monitoring 
happens at different levels: each level of the system has been designed for some amount of possible 
adaptation, but to different degrees. Also, every 12 years a review takes place and standards may be 
revised. After the Delta decisions are made and are implemented, there is ongoing monitoring of 
research (including commissioned research), innovation, climate change, socioeconomic conditions 
and societal preferences.  
Of the three core features of the Delta Programme, informed alertness is particularly challenging, given 
the task of distinguishing noise from signal while monitoring for tipping points.  
One must also note that: 
• In the Netherlands, the chance of drowning is communicated as a risk metric. The Dutch have 
the luxury of a homogeneous system where floods are technical issues. This is not always 
possible in other countries, which often leaves their representatives disillusioned. Some good 
Dutch examples may not function well in other systems. 
• Scale is important. Flood-prone regions are often not wealthy enough to pay for works on their 
own. Countries that are too large lack the solidarity for small, flood-prone areas. Mid-points in 
scale – of which the Netherlands as a whole is an example – are important. 
Informing adaptive management: Innovations and challenges  
As theory and practice make clear, the best response to deeply uncertain conditions is often to pursue 
strategies that are robust and adaptive. However, policy flexibility and experimentation can often 
conflict with the need for accountable, objective, and predictable governance. To address these 
challenges, decision support analytics can help decision-makers lay out well-articulated contingency 
plans, along with a clear understanding of the limits of these plans. Robert Lempert (RAND) described 
example applications and discussed institutional and other implementation challenges.  
He emphasised the need to distinguish between adaptive plans and the process of making them. 
Attributes of adaptive plans are: 
• Forward-looking, to identify potential vulnerabilities and responses 
• With automatic adjustments, to monitor and respond to vulnerabilities 
• Integrated, combining the management of multiple elements in holistic plans. 
Attributes of processes of developing plans include: 
• Integrative review and learning, to address emerging issues 
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• Multi-stakeholder deliberation, to promote legitimacy and access to information 
• Diversity of approaches, to gain knowledge about most effective approaches 
• Decentralised decision making, to improve flexibility and responsiveness. 
US EPA follows adaptive decision processes, but the resulting plans are less often adaptive. For 
instance, the EPA process for setting water quality standards includes the above four characteristics, 
but in practice the water quality standards do not easily change and while the implementation plans 
are commonly phrased as adaptive, they often rely mostly on unplanned learning. ‘Adaptive’ plans 
rarely stretch beyond branding into practice.  
Traditional risk management methods work well when uncertainty is limited, but in conditions of deep 
uncertainty, uncertainties are often underestimated, competing analyses can contribute to gridlock 
and misplaced concreteness can blind decision-makers to surprises. Under deeply uncertain 
conditions, it is often useful to run the analysis ‘backwards’, from the proposed strategy to the 
identification of vulnerabilities in the strategy, to the development of adaptation measures to reduce 
vulnerabilities.  
In the case of the Colorado Basin, this approach was used to develop an adaptive management plan. 
The plan included rule-based adaptive strategies with near-term actions, trends to monitor, and 
contingency actions, in order to keep indicators within acceptable levels by acting in good time. Such 
adaptive approaches can be thought of and designed in the context of triple loop learning, connecting 
and triggering revisions of decisions of different levels (e.g., plans, standards, and statutes). When a 
plan includes planned learning (“adapt as planned”), it reduces the need for constant revisions, which 
take place only in predefined circumstances.  
However, notwithstanding the usefulness of this analytic decision method, political constraints, legal 
challenges, and divergent expectations can hinder adaptive learning.  
Adapting to scientific information: An insurance perspective  
Trevor Maynard (Lloyd’s) described how Hurricane Andrew in 1992 led to a number of insurer 
insolvencies and was like a wake-up call to the insurance industry, paving the way for an influx of new 
scientific data to the market and a more serious consideration of catastrophe models. Scientific 
methods proved better than assumptions of claims stationarity and were finally accepted by 
insurers. Notably although Hurricane Katrina caused widespread wind and flood-related claims 
payments (USD80bn) there were very few insolvencies due in large part to the capital buffers set up 
using modelling insights.  
New models move away from treating events like hurricanes as stationary processes. Instead, they 
adopt a near-term view – and even a live forecast – of risk as an alternative to long-term averages. As 
such, they provide and interesting example for PAR. 
Despite this, there was much to learn from Katrina and models came under scrutiny. Notwithstanding, 
with all the analytical improvements, behavioural elements influence how well or bad forecasting is 
used. Changing a culture of analysis and forecasting requires overcoming some biases (e.g., herd 
behaviour, representation bias, availability bias, anchoring, and cognitive dissonance). 
The example from adaptive approaches from the insurance industry also underscores the importance 
of effective monitoring, as well as of high-quality data, and of improved risk communication among all 
the actors involved. Lloyd’s of London now requires formal uncertainty communication in its minimum 
standards. Amidst this, new risk networks are emerging as fora for linking academia to insurance. 
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The discussion emphasised that probabilities can be hard to understand, although large probabilities, 
such as daily rainfall, tend to be understandable to some extent. Yet for tiny uncertainties, even experts 
misunderstand these. Using the experimental literature to communicate uncertainty should help 
improve risk communication. 
 
Adaptive Regulation for the Development of Autonomous Cars  
Most risks involved in car driving will change with the advent of autonomous cars. Engineers, scientists 
and car manufacturers have developed technologies that enable personal vehicles to drive fully 
autonomously, but there are a number of uncertainties that will need to be resolved (including issues 
of standards and interoperability, safety, public acceptance, cyber security, and liability in case of 
accident). Risks and their management are being re-evaluated, notably by modelling the driving 
behaviour or the car, to enable accurate qualitative and quantitative assessment, and by addressing 
liability concerns that may otherwise slow or even prevent consumer access to advanced autonomous 
vehicle technology. The revision of vehicle regulation requires strong collaboration between 
regulators, insurance companies, car manufacturers and software companies, and an incremental 
approach that will allow adaptation of the regulation to the emerging autonomous vehicle 
technologies, as well as to the outcome of ex-post regulatory impact assessments that collect and 
integrate feedback from evidence (accident and incident databases) into planned revisions. The 
session discussed how new regulatory frameworks can be designed for fully autonomous cars. For 
example, EU regulation routinely uses ex-post impact assessment. It identifies actual impacts during 
and after implementation, to enable corrective action to be taken if necessary, and to provide 
information for improving the design of future interventions. 
Authorisation of autonomous vehicles could happen incrementally, promoting autonomous vehicles 
(AVs) for old, young or disabled people, who do not have access to the benefits that mobility provides. 
However, regulatory systems have low or negligible capacity at the moment for adaptations, or the 
high-resolution monitoring systems needed to back them up. 
Adaptive approaches to vehicle regulation  
Walter Nissler (UNECE) presented the work of the UN World Forum for Harmonization of Vehicle 
Regulations (WP 29) as the international body that establishes international legal instruments to 
govern the approval or certification processes for vehicles and their parts and components as a 
prerequisite to allow their use on public roads. It acts as the secretariat of international conventions, 
such as the 1958 Agreement on type approval for vehicles, parts and components and the 1998 
Agreement establishing Global Technical Regulations for vehicles, parts and components. These UN 
vehicle regulations deal with safety (general, passive and active), pollution and CO2 emissions, noise 
and light signaling. Regulations are mostly performance-based (e.g. maximum allowed acceleration for 
head and injury of the neck), avoiding design restrictions as much as possible. They are based on the 
principle of performance orientation, avoiding as much as possible design restrictions. To follow 
technical progress, they are regularly amended.  
The latest technical developments towards the introduction of automated and autonomous vehicles 
challenge the regulatory system at international level.  
Challenges include the adaptation of vehicle construction regulations, introducing new concepts of 
safety and interoperability; the integration of new technologies and standardization work (ITU, ISO, 
IEC, IEEE); extending regulation to cover software and updates; data and cybersecurity; and the 
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continuing consideration of traditional vehicle safety issues. Systemic challenges include mixed traffic 
versus separation; the adaption of traffic rules (e.g. safety distances), the adaptation of infrastructure; 
and the revision of concepts of responsibility and liability. 
Harmonisation is crucial for a global market. Open questions remain, such as what really needs to be 
regulated, when regulation is needed and the level of depth into which regulations should go. 
However, regulators should always seek for enhancement of safety for road users and avoiding unfair 
competition in the automotive industry. 
Adaptive regulation and autonomous cars: Views from the UK regulator 
Ian Yarnold (UK Department for Transport) presented the initiatives from the UK Department for 
Transport (DfT), as an early mover in autonomous vehicle policy. There have been prize funds within 
the UK for innovation, and a large review in 2015 called The Pathway to Driverless Cars. Three main 
deliverables arose from this project: a code of practice (Spring 2015), the intention to review and 
amend domestic regulation (Summer 2017), and work preparing international discussions for 
regulatory change (2018).  
Driverless vehicles can legally be tested on public roads in the UK today. 
Enabling this has been the ‘adaptive interpretation’ of regulation in order to allow trials. The Code of 
Practice interprets these much older regulations, some over 150 years old, in a way favourable to tests 
of autonomous vehicles on UK roads.  
Areas where domestic adaptation will be required are in liability; licensing; data security/ownership; 
road traffic rules. International adaptation will centre more around vehicle standards; cross-border 
issues and conventions; cyber-security; and over-the-air updates. 
Informing regulations for autonomous vehicle technologies 
Autonomous vehicles have long been a staple of science fiction and Hollywood. In the coming decades, 
they may become a staple of our everyday lives, with potentially transformative effects. Managing 
their risks and maximising their benefits requires carefully designed governance and regulation.  
Nidhi Kalra (RAND) presented a calculus of risk and benefit over time in order to open up the debate 
around AVs and regulatory action. AVs promise greater safety, mobility and efficiency, as well as better 
land use and reduced congestion. Yet they may also bring economic disruption, increased demand for 
vehicle miles, sprawl and the decrease of mass transit. 
The safety issue is a prerequisite for both the opportunities and challenges: how safe should 
autonomous vehicles be before they are allowed on the roads, and how do we prove they are safe? 
While humans can make mistakes, there is a cultural aversion to ‘letting machines make mistakes’. 
Some will insist that for introducing AVs, anything short of totally eliminating risk is a safety 
compromise. However, waiting for autonomous vehicles to be perfect itself raises safety concerns, 
because it would mean the needless perpetuation of the well-documented risks posed by human 
drivers. Kalra proposed that AVs might optimally be introduced when they are just somewhat safer 
than human drivers (perhaps for use by the least safe human drivers) – or arguably even when the AVs 
are not yet quite as safe as (safer) human drivers, because this earlier introduction of still-imperfect 
AVs can enable faster learning to improve AVs (so that AVs more rapidly outperform human drivers) 
and thereby reduce overall driving risks more steeply.  
Technological uncertainty, public acceptance, and a host of other factors make it difficult to develop 
sound governance around this potentially disruptive technology. Deep uncertainties make it very 
difficult to develop appropriate regulation, so testing and pilot programs seem key in order to collect 
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data to help generate knowledge and reduce uncertainty. Then, performance-based regulations will 
offer possibilities for governing the technology in a forward-looking manner. Adaptive regulation holds 
opportunities for governing this technology. 
Insurance perspective on automated vehicles  
Sebastiaan Bongers, Swiss Re, presented an analysis on adoption of AVs over time, and the changing 
patterns of projected global vehicle risk. Motor vehicle insurance currently accounts for approximately 
42% of the total global primary Property & Casualty market and is one of the most important lines of 
business for insurance companies. Motor insurance is undergoing a transformation as new 
technologies, such as telematics, give rise to new business models.  
Bongers observed that AVs have the potential to significantly reduce the number of automobile 
accidents. Swiss Re developed several projections to get a better understanding of the important 
factors influencing auto insurance over the next two decades. In the long run, as AVs are more widely 
adopted, the amount of risk and therefore the need for personal motorist insurance coverage is 
anticipated to decrease, while product liability insurance coverage by AV manufacturers may become 
more important. 
However, in the short term insurers anticipate that, globally, the amount of risk will still increase over 
the next few decades. This is due to slow adoption rate, population growth and emerging markets, and 
insurance being about theft, damage, etc. – more than just accidents. Even in an extreme demand 
scenario, where people would rush to buy and drive AVs, risks actually stay stable in the medium term, 
rather than reduce as we might expect.  
Currently, insurers have different approaches to tackling the transition phase. Besides thinking about 
the liability aspects and policy wordings, insurers will have to build capabilities to assess the automated 
features in new cars in order to be able to price risks accordingly.  
 
Conference Day 2 
Adaptive Risk Governance in Synthetic Biology  
In the past five years, the field of synthetic biology has been developing at an extraordinary pace. 
Exponential declines in the cost of DNA sequencing have led to exponential increases in the quantity 
and quality of information in genetic databases, while exponential declines in the cost of DNA synthesis 
and the development of powerful new tools for gene editing such as CRISPR Cas-9 have facilitated the 
development of industrial, agricultural and environmental applications of synthetic biology. The 
session discussed: 
• Benefits and risks associated with applications of synthetic biology, including synthesis of fuels, 
flavours and drugs in contained settings, the development and release of genetically modified 
plants and animals, with applications to agriculture and to modification of wild populations 
• Proposed technical measures that may mitigate risks and methods for the evaluation and 
certification of technical measures 
• Policy issues associated with risk regulation including EU reforms and US revisions of the 
Coordinated Framework for Regulation of Biotechnology. 
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Regulation is often viewed as the preferred or default option for minimising the risks and uncertainties 
associated with rapidly emerging technologies such as synthetic biology. The evolving nature and 
special characteristics of synthetic biology suggest the need for an ‘expanded toolkit’ beyond 
regulation to promote adaptive governance and to better tailor appropriate measures to specific 
situations. This includes not only legal liability regimes, insurance, soft law mechanisms, ‘regulation by 
contract’ and standards, but also integrating risk-based issues and gaps with less familiar tools such as 
technical roadmaps, research consortia agendas, and innovative business models incorporating 
‘adaptive advantage’. 
Introduction 
Jim Philp, OECD, introduced the session by reminding that, although there is a consensus about the 
need for a new regulatory regime for bio-based production, there is very little agreement about what 
it might look like. The US focuses on the need to streamline the many agencies involved and apply 
rules for each product application rather than for each production method or technique. The EU has 
more complex rules for the acceptability of genetic modification for agriculture, but it is not clear to 
what extent this is an issue in industrial-scale contained use applications.  
The introduction to the session asked if standardised tests for biocontainment are suitable for 
regulatory requirements: is it possible to design laboratory standard tests that would be harmonised 
across national boundaries and that guarantee an acceptable level of biocontainment, can be readily 
performed by standard laboratories, can be legalised and will shorten and streamline the regulatory 
process to enable business and innovation in this field? 
Synthetic biology: Governing risks of emerging applications  
Kenneth Oye (MIT) discussed how the generalisations on benefits and risks associated with ‘synthetic 
biology’ should be replaced by concrete analysis of specific applications. His talk summarised several 
current and impending applications and standards of synthetic biology with distinctive benefit/risk 
profiles: 
• Synthesis of high-value products (drugs and flavours) in tightly contained settings 
• Synthesis of low-value products in semi-contained settings 
• GM agricultural crops and livestock 
• Gene drives to propagate genetic modifications in wild populations. 
He then discussed technical safeguards that may limit potential environmental and security risks 
(methods of intrinsic containment, including nutrient dependency and codon knockouts, immunisation 
drives and reversal drives) and flagged regulatory challenges associated with certification of safeguards 
and management of risks.  
In particular, Kenneth Oye noted some of the mismatches, gaps and quirks of the current regulatory 
system to deal with health, environmental and security issues in a field where technology is 
increasingly ahead of regulation.  
Most current applications of biotechnology use new methods to accomplish conventional ends, such 
as synthesizing materials or changing the properties of crops. Some emerging applications of 
biotechnology use new methods to accomplish unconventional ends, such as editing the genes of wild 
populations, not anticipated when the US and European regulatory frameworks were promulgated. 
Both conventional and unconventional applications cut across existing jurisdictional boundaries and 
raise issues that fall beyond the purview of US and EU agencies. 
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Starting with conventional applications, bacteria, yeast and algae are currently being used to produce 
high-value drugs, scents and flavors, medium value industrial chemicals, and low-value biofuels. In low-
value settings where expensive physical containment may not be economically viable, debate will focus 
on the effectiveness of biological containment measures in limiting environmental effects associated 
with inadvertent release. Methods of intrinsic containment have progressed from simple kill switches 
to advanced work on multiple nutrient dependency strategies to reduce fitness and on engineered 
genetic codes to limit horizontal gene transfer. There is need for development of protocols for testing 
and certifying methods of biological containment.  
 
Turning to unconventional applications, gene drives are being developed to suppress invasive species 
and control vector-borne diseases by driving genetic alternations through wild populations of sexually 
reproducing plants and animals. The EU debate is just beginning. Within the US, the fit between this 
novel application and existing lines of jurisdiction is being discussed. FDA has responsibility for 
evaluating genetically engineered DNA constructs intended to affect animals under provisions for 
veterinary medicines. USDA could be involved if alterations will affect livestock or crops. EPA has broad 
responsibility for environmental implications of alterations. State authorities have expressed an 
interest in evaluating local environmental effects. All Federal and State agencies underscore the need 
for information on gene drive mechanisms, environmental and security effects, and technical features 
to limit potential environmental and security effects, including immunization drives and reversal 
drives. However, no agencies have stepped up to provide funding for such research.  
 
Finally, technical developments in the methods used by biological engineers pose regulatory 
challenges. Consider three examples. US EPA defines “genetically engineered” organisms as those to 
which DNA from a different taxonomic genus has been added. With new knowledge of genomics and 
new genetic engineering technologies, genetic changes with the potential substantially to affect an 
organism and its ecosystem can be made through deletion, duplication, or even rearrangement of 
genetic sequences within a given species or genus. Such changes now fall into a regulatory gap. EPA 
defines “genetically engineered” as an organism produced through deliberate movement of DNA. 
Directed evolution has become more powerful through the use of new DNA sequencing technologies. 
Changes made through directed evolution now fall into a regulatory gap. EPA treats instability of 
genetic constructs as undesirable. Some technical methods of intrinsic containment may deliberately 
build in instability to degrade the efficiency of constructs in order to localize potential effects. 
Ironically, regulations designed to protect the environment may preclude application of a potentially 
significant containment strategies. 
Approaches to risk governance under uncertainty could take the following forms: 
• 'Permissive': they must allow innovation unless environment, health, security are clearly 
compromised. After-the-fact reaction must be in place if a crisis materialises, because backlash 
may limit innovation. Examples include: Post-Fukushima nuclear shutdown, US stasis on gene 
therapy 
• Precautionary: they must limit innovation unless environment, health and security are clearly 
protected. The diversion of innovation to less regulated areas may heighten risks. Examples 
include: EU on GMOs, US on stem cell research, German genetic data protection 
• ‘Planned adaptive’: they must prepare (fund research to inform priors on benefits and risks), 
discriminate (foster initial applications with most favourable priors), observe (harvest and 
process information from initial experience) and adapt (learn from experience and 
update/correct practices). 
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Scientific opinions on synthetic biology in the EU  
Theo Vermeire (RIVM) introduced the field of synthetic biology as full of exciting possibilities, from 
adapting crops to thrive in barren lands to growing new organs to save the lives of transplant 
recipients. As an unexplored scientific territory, synthetic biology also poses potential risks and there 
is inherent uncertainty regarding these risks. That is why a Working Group under the three non-food 
Scientific Committees of the European Commission, the Scientific Committee on new and Emerging 
Health Risks (SCENIHR), the Scientific Committee on Health and Environmental Risks (SCHER) and the 
Scientific Committee on Consumer Safety (SCCS) recently answered 11 questions on synthetic biology 
from DG SANTÉ, DG RTD, DG GROW and DG Environment. 
Three Opinions were presented. The first Opinion (September 2014) discusses the elements of an 
operational definition for synthetic biology and its scope. The two Opinions that followed in 2015 
focused on risk assessment methodology, safety aspects, specific risks for the environment, knowledge 
gaps and research priorities. 
The presentation also suggested ideas regarding the widely discussed risk governance of an emergent 
technology like synthetic biology, which is seen as an extension of GM. Emerging technologies 
increasingly seem to give rise to questions about the safety of their products alongside questions on 
socio-economic issues, including ethical issues. When fundamental uncertainty exists on the risks and 
insights in (new) safety aspects are lagging behind the development of new technologies, appropriate 
legislation cannot be developed timely, public perceptions may be less favourable and innovation may 
slow down.  
When talking to regulators and the public, synthetic biology practitioners tend to emphasise continuity 
with the past; when talking to prospective funders, they emphasise novelty. Even within scientific 
communities there are differing opinions. Emergent properties of synthetic biology are expected to 
create new challenges with regard to the prediction of risk. Built in ‘safety locks’ are currently not 
sufficiently reliable, and are not blanket solutions. Different layers and methods of containment should 
be combined to increase safety. The safe innovation model being developed at RIVM includes the use 
of ‘safe houses’ to experiment with different regulations, and risks can be managed early on. 
Biotechnology: View from industry 
Neil Goldsmith (Evolva) presented the activity of his company, which combines modern biotechnology 
and traditional fermentation to produce ingredients with supply chain ‘issues’: “brewers for the 21st 
century”. These approaches offer major benefits in terms of better, healthier ingredients for people 
around the world, produced in a safer and more affordable manner, with a lower ecological footprint 
than what has come before. Evolva’s ingredients can help individuals reduce the amount of sugar in 
their food, protect their families from disease-transmitting insects and improve the health and 
wellbeing of themselves and their pets. 
Over the last few decades, society has put in place extensive regulations regarding both 
biotechnological processes and the products (medicines, food, household goods, fuels, crops) that 
such processes can impact and improve. These regulations are not just passive, however, but 
themselves actively shape the flow of how (and which) technologies develop. Whilst crafted with 
positive intent, such regulations, especially those that emerge as the result of complex political 
processes, may also have perverse effects. For example, the Convention on Biological Diversity was 
designed (in part) to promote the sustainable exploitation of biodiversity, but has instead played a part 
in getting the pharmaceutical industry to adopt alternate technological methods for generating new 
 Planning Adaptive Risk Regulation Conference Report  //  19 
medicines, resulting in them largely abandoning biodiversity as a source, in turn reducing (at least in 
commercial terms) the value of biodiversity. 
As new biological technologies continue to come through, it is important to update existing regulatory 
frameworks. However, such updates must not only seek to reduce risk, they must also seek to capture 
the benefits of innovation, and to avoid perverse effects. This is becoming ever trickier, given that the 
rate of technological change is exponentially increasing, whilst the rate of regulatory change is not. As 
such, the risk that regulations are not adapting, or are adapted poorly, increases. 
Neil Goldsmith posited that synthetic biology is thus more of a way of thinking than a product. The 
contrast is that instead of a top-down approach, synthetic biologists look from bottom-up to create 
new functionality. Can you regulate a philosophy? Without considering the consumer benefits, there 
will be a repeat of the folly of the genetically modified (GM) organisms industry. There is increasingly 
a fusion of biotech and IT in order to develop agile technologies and methods of creation. Neil argued 
that it is important to encourage self-regulation, given the complexity and speed we see. In parallel to 
this, academia and industry (where it exists) must be encouraged to be transparent and engage society. 
Neil Goldsmith argued that products secreted from a GM organism are not GM. They are similar to 
those created with a GM product. Already there are 10–15 products based on synthetic biology, soon 
there may be hundreds or thousands. 
 
Adaptive Risk Governance in Precision Medicine 
The term ‘precision medicine’ is used with reference to two broad areas of application: 
• Conventional pharmaceuticals are being used in increasingly discriminating ways, with 
genotypic and phenotypic information on efficacy, safety and effectiveness of drugs and 
advanced diagnostic tests on patients, which are used to focus treatments on smaller 
subgroups of patients 
• Unconventional regenerative medicines and somatic gene therapies are developed and 
administered to genetically defined treatment groups, with some therapies based on 
modifications of cells extracted from individual patients. 
Development, regulation and payment/reimbursement for precision medicines, defined in both 
senses, pose challenges to conventional methods of governing benefits and risks. The session 
discussed some of the governance issues associated with precision medicine, including that: 
• Conventional methods of governing benefits and risk to very small treatment groups are 
challenged 
• One central element of precision medicine, that is the need to collect and integrate large sets 
of data, including genetic, health and environment (life-styles), may cause problems of data 
access and use.  
Introduction to the revolution of precision medicine  
Gérard Escher (EPFL) posited that precision medicine results from the digital and the genomic 
revolutions, which announce a new patient-centric and data-intensive medicine. The ‘info-nano-bio-
cogno’ convergence of knowledge is leading to an abundance of data and capacity to extract meaning. 
Research, clinical trials, informed consent, liability, privacy, and health insurance will be transformed.  
But to meet the promises, more data needs to be collected, medical doctors need to be trained and 
theory and technology must align. The huge cohorts needed for making sense of genomes brings 
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challenges of data quality, size and privacy in order to make reliable, ethical analysis, alongside 
challenges of re-skilling doctors to deal with probabilistic counselling and analytical rigour. Without 
the right balance of individual rights and public health concerns, we risk bypassing the current health 
infrastructures and regulations. Perhaps we need a Nagoya Protocol for the exchange of human 
genetic data and resources.  
An adaptive regulatory framework for responsible sharing of medical and health-related data and for 
protecting patient rights is necessary. Countries in Europe and elsewhere are embarking on ambitious 
policy initiatives and research programmes. 
Precision medicine: An overview of changing technologies and regulatory challenges  
The presentation from Kenneth Oye (MIT) provided an overview on technical and policy issues 
associated with the development and regulation of precision medicines, and its various forms (e.g. 
altering genes, regenerative medicine, germline gene therapies, etc.) 
Challenges include: 
• Characterisation of degrees of uncertainty over benefits and risks associated with conventional 
and unconventional precision medicines: how to assess safety and efficacy when the numbers 
are small and it is even difficult to find enough subjects for random clinical trials 
• Cost and governance issues that are associated with ever smaller treatment groups: for rare 
disorders, prices are climbing, and payers demand more evidence despite weak information. 
On the other hand, patients would like to have early access to therapies. Patients are exposed 
to high risk in early use 
• Problems with data collection, access and use. 
The European Medicine Agency (EMA), US FDA and Japanese PMDA regulatory authorities are 
innovating to meet these challenges. In particular, EMA is moving towards adaptive pathways for drug 
licensing, which could also be needed for precision medicine. 
Governance debate and policy agenda: The situation in China  
Lan Xue, Tsinghua University described the various actors addressing precision medicine and their 
different motivations: the scientific community is currently driven and/or concerned by data access, 
government and society are motivated by data privacy and security, committees on ethical, legal and 
social issues (ELSI) are motivated by ethical issues, and government & industry are driven by economic 
opportunities.  
China is an important player in genomic research and technology, with anticipated application in 
precision medicine. Initially, genetic test labs were approved at a provincial level. Following negative 
news publicity, these were all called off from a national standpoint – the reason being that the products 
were unregistered. Following this, some pilot technologies and institutions were authorised. However, 
the core trouble here for adaptive regulation is how to coordinate services when different agencies 
have different agendas and responsibilities.  
Genomic research and precision medicine  
Jacques Fellay (EPFL) reminded that rules and regulations governing research and clinical activities 
have historically been very distinct. In today’s post-genomic era, every patient – or healthy individual 
– can be seen as a potential research participant, whose data could contribute to an accelerated pace 
of scientific discoveries. Open access and citizen science movements are powerful forces that are 
reshaping the biomedical research enterprise, but their current lack of regulatory content is 
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problematic when dealing with private health data from the general population. The presentation 
described the promises and pitfalls of the upcoming confluence between laboratory and clinical 
genomics, from the perspective of a medical doctor active in human genomic research. 
There is a blurred line between clinical care and genomic research. A central goal of precision medicine 
is to focus, at the individual level, on wellness and progression to disease, rather than disease and 
progression to death. Currently, genomic medicine looks at rare diseases, limited connections between 
genes and drugs, genomics of cancer and non-invasive prenatal testing. However, in the future, 
universal sequencing, sensors, new levels of data and understanding, and clinical access to technology 
will mean that genomic medicine becomes much more mainstream. 
Regulatory challenges of bringing precision medicine to patients 
Hans Georg Eichler (European Medicines Agency) described one of the key problems of precision 
medicine: it is challenging to detect all problems before licensing, or even within decades or 
generations of their use. This creates a high reputational risk. Post-market studies are a problematic 
tool and, if they are not delivered, it is difficult or impossible to withdraw the product.  
Adaptive pathways require us to think over a few points:  
• Stop pretending that we know everything at the time of licensing 
• Classic medicines do not normally spread like wildfire, we can generally recall them. This may 
not be possible with precision medicine 
• Authorisation can be a graded decision, not binary. Rather than licensing a medication for all, 
we can determine and limit the treatment-eligible population – starting for example with the 
population with the biggest unmet need 
• We can steer use of the product: the reauthorisation of thalidomide is a good example, 
accompanied by a complex risk management scheme with a patient registry and monitoring 
system 
• Perhaps there are relevant price controls: can we link products to their uncertainty to promote 
knowledge building? 
 
Concluding Session and Synthesis 
The concluding session was a discussion among Arthur Petersen (UCL), Reto Schneider (Swiss Re), 
Jonathan Wiener (Duke University), Anne Glover (University of Aberdeen), and Jason Blackstock (UCL). 
This discussion highlighted the following points. 
While implementing Planned Adaptive Regulation can be challenging, doing so is often worth the extra 
effort because PAR represents an effective and efficient approach to regulating old, new and disruptive 
technologies in the face of uncertainty and evolving circumstances. 
PAR is a dynamic approach to regulation. Instead of waiting for certainty, or making a one-time 
decision, it embraces uncertainty through a plan for the design, monitoring, review and sequential 
adjustment of policies. PAR incorporates learning from (controlled) implementation, with that learning 
feeding directly into review and rule-adjustment. 
The conference highlighted some of the many tools and types of PAR currently being used and 
proposed, and how the form of PAR may change given the characteristics of particular risks. It also 
raised some key enabling and confounding dynamics that may determine the success of any 
implementation. 
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(a) There are many tools and types of PAR. Ways to implement PAR approaches include:  
• Revision processes: planning for single or periodic reviews of ongoing policies, or mechanisms 
designed to periodically challenge fundamental regulatory assumptions and criteria 
• Sunset clauses, or other mechanisms to terminate a policy unless it is reviewed and renewed 
• Learning: the ability to observe variation and/or conduct experiments, to monitor/collect data, 
and to modify/improve regulation as one gains experience with the risks and benefits 
• Building in planned rule adjustments, usually linked to ‘signal standards’, which are often 
performance-based 
• Maintaining the option space: keeping long term avenues open using procedures such as 
backcasting 
• Fostering adaptive policy systems, where institutional rules and practices promote adaptation 
of regulation when new information emerges 
• ‘Front-end’ PAR through ex ante impact assessment of new or revised policies, as well as 
through limited release and deployment of technologies (such as adaptive licensing of 
medicines or performance-based certification of active safety features for automated driving) 
for the specific subgroups who would benefit most (followed by testing and assessment of 
wider licensing) 
• ‘Back-end’ PAR, through ex-post impact assessment (retrospective review) to assess and revise 
existing regulations, as well as to test and improve the accuracy of ex-ante impact assessments 
• ‘Red teams’ whose job is to attempt to break or game regulatory systems to help identify 
problems and aspects in need of revision. 
Assessment mechanisms are crucial parts of the PAR toolkit. The impacts of each PAR should be 
thoroughly assessed – ex-ante and ex-post, or repeatedly – since the amount of risk we are willing to 
take is strongly reliant on the cost–benefit balance. Failed and successful cases of PAR should be 
studied in order to improve the assessment of potential losses and benefits of new planned adaptive 
rules. 
Communication and education tools often determine the success of PAR. In the communication sphere, 
the framing of technologies (e.g. as ‘new’ or as ‘amended’), the extent to which probabilities are 
understood and related to by audiences, the role of scientists and independent bodies in supporting, 
structuring and synthesising information are all important. Benefits and costs are often unevenly 
distributed across actors with different incentives, information and risk tolerance, and communication 
can unify or polarise these situations. Awareness of cognitive biases may aid communication in this 
area. 
(b) The form of PAR may differ based on the characteristics of particular risks, benefits and 
technologies.  
The different timescales of costs and benefits create important practical implementation 
considerations and normative, distributional decisions. The sequential reviews of PAR need to be timed 
to keep pace with the evolving science and technology of each issue area. For PAR to succeed, the 
reviews cannot be too seldom or too frequent, and adjusting the timescale itself will require 
experiments and learning from experience. Even within the same timeframe, different populations can 
experience different levels of impact or risk with different levels of uncertainty. In some cases, the idea 
of targeting specific subgroups or populations over time was raised – yet the ethics and calculus of this 
are rarely clear. Different risks also have different scopes of impact. At the design phase, policymakers 
can better minimise unintended consequences by paying attention to the full portfolio of impacts, 
including the ancillary benefits and countervailing risks. PAR needs to consider a broad array of types 
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of changes, looking beyond scientific and technological developments to include social, economic, 
demographic and political changes, among others. The conference identified some examples where 
promising PAR systems were hampered by these broader changing factors. Risk and technologies also 
bring many types of uncertainty. Some knowledge gaps are obvious, while other will appear with time: 
yet a strong research programme, while possibly even increasing uncertainty, should help us better 
characterise it. We can learn a lot about some technologies and policies in controlled experiments, 
while for others we can learn very little. Yet despite these characteristics, it is important to realise that 
evidence is rarely value-free, and we rarely are able to classify emerging risks well, or understand many 
of their features. 
(c) Finally, PAR cannot be achieved in a vacuum, but is surrounded by both key enabling and 
confounding dynamics which should not go unconsidered.  
PAR might be able to improve accountability for policy outcomes, but will be unlikely to achieve this 
without an institutional culture of transparency. In order to detect risks, foresight and horizon scanning 
organisations play a useful role at the forefront of understanding trends. Linked to this, there should 
be strong research capacity to better characterise and clarify remaining uncertainties, with research 
structures well connected to policy structures. A key question will be who conducts and oversees PAR: 
which institutions in each polity have the authority and responsibility to undertake the research, 
reviews, and policy revisions. Certain legal systems appear more amenable to particular types of PAR 
than others, especially those where performance outcomes, rather than users’ behaviors, are 
regulated; where rapid adjustment is possible; and where older legislation can be ‘adaptively’ 
interpreted. Particular political systems are also easier to navigate for PAR – with many examples of 
PAR at the forefront coming from systems with internal variation as a source of learning. PAR requires 
credible future commitment, else adaptation may not occur as planned, and a balance between 
adaptability and the predictabilty sought by investors. Issues of scale need careful consideration. Policy 
variation across subjurisdictions can offer a laboratory for learning – provided that some institutions 
are actually monitoring this variation and learning from the results. Over-decentralisation can lower 
capacity for policy experimentation, while over-centralisation can stifle innovation. Similarly, regional 
risk management needs to strike a balance between resource availability and political solidarity with 
the affected area. New boundary organisations for brokering between evidence and practice seem to 
support PAR, such as academic networks in the insurance field. Educational leadership in risky fields 
can create an atmosphere of responsibility and self-regulation. New policy-makers should also be 
trained to use PAR approaches when designing and managing risk. An inclusive, multi-stakeholder 
culture helps to better share experience and affirm that PAR can unlock social benefits while being 
compatible with stability and safety. For this, it is important to investigate and learn how actors have 
been positioning themselves in ongoing PAR initiatives, and how PAR may affect the political economy 
of regulation in the future.  
A culture change might be necessary: from relying on and aiming at rigid and permanent political 
agreements, to perceiving and accepting policies as dynamic experiments, contingent on evolving 
circumstances and advancing understanding. PAR may then be linked to guiding principles for dealing 
with uncertainty and incorporating learning into policy systems: how to produce decision-relevant 
knowledge over time, and how to link that knowledge to continual decision-making. 
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Appendix 1: Conference Programme 
 
Day 1 – Thursday 7 January 2016 
 
Session 1.1: Introduction 
• Welcome from University College London 
Jason Blackstock, Department of Science, Technology, Engineering and Public Policy 
(STEaPP), University College London 
• Welcome from IRGC 
Philippe Gillet, École Polytechnique Fédérale de Lausanne; IRGC Foundation Board 
• Considerations in the design of adaptive policies 
Granger Morgan, Department of Engineering and Public Policy, Carnegie Mellon University; 
IRGC Scientific & Technical Council (S&TC) 
• What is planned adaptive regulation? 
Arthur Petersen, UCL STEaPP; IRGC S&TC 
• What happens if regulation is not adaptive? 
Anne Glover, University of Aberdeen, former Chief Scientific Adviser to the President of the 
European Commission 
 
Session 1.2: Adaptive Regulation – An overview of past and current experiences 
Facilitation: John Graham, Indiana University 
• Fuel-economy/carbon standards for motor vehicles 
John Graham, School of Public and Environmental Affairs, Indiana University; IRGC S&TC 
• Planned adaptation in retrospect – Lessons from exemplary cases and cautionary tales 
Kenneth Oye, Program on Emerging Technologies, Massachusetts Institute of Technology; 
IRGC S&TC 
• Adaptive risk regulation and fracking in Europe 
David Reiner, University of Cambridge 
• Commentaries: Ragnar Löfstedt, King’s Centre for Risk Management, King’s College London 
 
Session 1.3: Adaptive flood risk governance 
Co-organised with: Dutch Delta Programme 
Facilitation: Arthur Petersen, University College London 
• Introduction 
Arthur Petersen, Department of Science, Technology, Engineering and Public Policy, UCL; 
IRGC S&TC 
• Dutch adaptive delta management 
Pieter Bloemen, Dutch Delta Commissioner 
• Informing adaptive management – Innovations and challenges 
Robert Lempert, RAND Corporation 
• Adapting to scientific information – An insurance perspective 
Trevor Maynard, Lloyd’s 
 
Session 1.4: Adaptive regulation for the development of autonomous car markets 
Co-organised with: Sustainable Transport Division, World Forum for Harmonization of Vehicle 
Regulations, United Nations Economic Commission for Europe 
Facilitation: Jonathan Wiener, Duke University 
• Adaptive approaches to vehicle regulation 
Walter Nissler, Vehicle Regulations and Transport Innovations Section, Transport Division, 
United Nations Economic Commission for Europe (UNECE) 
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• Views from the UK regulator 
Ian Yarnold, International Vehicle Standards Division, UK Department for Transport 
• Informing regulations for autonomous vehicle technologies 
Nidhi Kalra, RAND Corporation 
• Insurance perspectives on automated vehicles 
Sebastiaan Bongers, Swiss Re 
 
Day 2 – Friday 8 January 2016 
 
Session 2.1: Adaptive risk governance in synthetic biology 
Co-organised with: OECD Working Party on bio-nano-converging technology (WP BNCT) 
Facilitation: Kenneth Oye, MIT 
• Introduction 
Jim Philp, OECD 
• Synthetic biology: Emerging applications and regulatory challenges 
Kenneth Oye; Program on Emerging Technologies, Massachusetts Institute of Technology; 
IRGC S&TC 
• Scientific opinions on synthetic biology in the EU 
Theo Vermeire, Dutch National Institute of Public Health and the Environment and SCENIHR 
• Views from industry 
Neil Goldsmith, Evolva 
• Commentaries: Richard Kitney, Imperial College London 
 
Session 2.2: Adaptive risk governance in precision medicine 
Facilitation: Lan Xue, Tsinghua University 
• Introduction to the revolution of precision medicine 
Gérard Escher, École Polytechnique Fédérale de Lausanne; IRGC S&TC 
• Precision medicine – An overview of changing technologies and regulatory challenges 
Kenneth Oye, Program on Emerging Technologies, Massachusetts Institute of Technology; 
IRGC S&TC 
• Governance debate and policy agenda – The situation in China 
Lan Xue, School of Public Policy and Management, Tsinghua University; IRGC S&TC 
• Genomic research and precision medicine 
Jacques Fellay, École Polytechnique Fédérale de Lausanne 
• Regulatory challenges of bringing precision medicine to patients 
Hans-Georg Eichler, European Medicines Agency 
 
Session 2.3: Conclusion – Cross-cutting themes 
Facilitation: Arthur Petersen, UCL 
• Reto Schneider, Swiss Re 
• Jonathan Wiener, Duke University 
• Anne Glover, University of Aberdeen 
• Jason Blackstock, University College London 
  
 
Planning Adaptive Risk Regulation Conference Report  //  26 
Appendix 2: A Short Introduction to ‘Planned Adaptive 
Regulation’ 
 
This short note was written to set the scene before the conference on Planned Adaptive Risk 
Regulation (PAR) held by the International Risk Governance Council (IRGC) at University College 
London (UCL) on 7-8 January 2016. Its purpose was to propose a brief literature review about PAR, 
including main features, examples in practice, and reasons why PAR is desirable or may face challenges 
in each case. 
 
Introduction: How can law and regulation keep pace with scientific, technological and social change? 
Regulation of risk can be difficult in sectors marked by rapid change in science, technology, economic 
and social conditions. Regulators rely on projections of future outcomes, but also anticipate that actual 
outcomes may differ and will require rethinking over time as new knowledge becomes available. In 
fields where context conditions change rapidly, regulation cannot be a one-time final decision; 
continuous or iterative re-evaluation is needed for policies to keep pace with change. Addressing this 
‘pacing problem’ calls for adaptive regulation. Adaptive regulation may also help promote and 
accommodate innovation, avoiding lock-ins and barriers, through repeated evaluation and revision.  
At the same time, adaptive regulation may pose new challenges for regulators, regulated parties and 
other stakeholders. Periodic re-evaluation and revision might reduce the stability and predictability of 
rules, which could have the effect of discouraging investment and innovation. Yet some instability is 
inescapable, because the underlying reason for adaptive regulation is that ongoing changes are 
occurring in the scientific, technological, economic and social conditions. Given that such change is 
ongoing, the promise of planned adaptive regulation is to handle this change with greater agility and 
predictability, through planned review and revision, rather than through a purportedly final decision 
that locks regulation in place and then grows increasingly out of step with the ongoing changes – 
yielding unintended consequences and rigid rules that inhibit innovation (until high costs or a crisis 
event force an abrupt and painful overhaul). Thus, planned adaptive regulation may be better able to 
address changing science, technology and conditions, while assuring regulated and affected parties of 
sufficient foreseeability to guide investment and decisions.  
 
Elements for a definition of Planned Adaptive Regulation 
The term ‘planned adaptive regulation’ refers to the intentional and precursory design of institutions 
and processes to review and update policies in light of evolving scientific knowledge and changing 
technological, economic, social and political conditions. It is adaptive, but also planned, so it refers not 
only to the ability of policies to respond to events and information as they arise, but also to a conscious 
plan to undertake data collection and repeated review over time. Our use of the term PAR is reserved 
for cases where: 
a) There is a prior commitment, planned early in the policy’s design, to subject the policy to 
periodic re-evaluation and potential revision, and  
b) There is a systematic effort or mechanism, planned early in the policy’s design, to monitor and 
synthesise new information for use in the re-evaluations.   
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References and illustrations 
Planned adaptive regulation has been used in various sectors. This section provides some references 
and illustrations from the literature. 
• Air pollution, airplane safety and drug safety (USA) 
 
”In principle, we want regulatory programs to be based on current realities, as reflected for 
example in the best knowledge of relevant experts. That would imply that old rules now on the 
books should be consistent with today's knowledge base, not just what was known when a rule 
or standard was originally set. This paper reports on a survey of US programs, examining how 
often existing rules are actually updated in light of better knowledge, and identifies five 
programs that attempt to make policy routinely adaptive. These programs exhibit what we 
term Planned Adaptation: they both revise rules when relevant new knowledge appears, and 
take steps to produce such improved knowledge. While Planned Adaptation is rare, it is used 
in several nationally prominent programs, including air pollution, airplane safety, and drug 
safety. Planned Adaptation is a policy tool that deserves more attention.” 
Lawrence E. McCray, Kenneth A. Oye and Arthur C. Petersen (2010): “Planned adaptation in 
risk regulation: An initial survey of US environmental, health, and safety regulation”, in 
Technological Forecasting & Social Change Vol 77 (2010) 951–959, available from 
http://www.sciencedirect.com/science/article/pii/S0040162509001942  
 
• Flood management (The Netherlands) 
 
“In the Netherlands, dykes and other primary water defence works are assets that are essential 
to keep the society and economy functioning, by protecting against flooding from sea and rivers 
due to extreme events. Given that 55% of the country is at risk of flooding, primary water 
defence works belong to its critical infrastructure. Many factors influence the risk and impact 
of flooding. Besides physical factors (e.g., landscape design, climate change), also socio-
economic factors (e.g., population, assets) are important. Given that these factors change and 
feature complex and uncertain behaviour in past and future, the design and regulation of this 
critical infrastructure will have to be flexible enough to be able to deal with such changes. 
‘Planned Adaptation’ refers to regulatory programmes that plan for future changes in 
knowledge by producing new knowledge and revising rules at regular intervals. This study 
describes the emergence of the next generation of Dutch primary water defence infrastructure, 
which through the stepwise implementation of Planned Adaptation for design and testing of 
primary water defence works in the mid-1990s has moved beyond the Delta Works approach 
of 1953 and subsequent unplanned adaptations. This has prepared the ground for the recent 
introduction of Adaptive Delta Management, which makes an integral part of the new Delta 
Plan for the Netherlands that was published on 16 September 2014 and which is also analysed 
in this study.” 
Arthur Petersen and Pieter Bloemen (2015): “Planned Adaptation in Design and Testing of 
Critical Infrastructure: The Case of Flood Safety in The Netherlands”, in Dolan, T and Collins, B, 
(eds.) International Symposium for Next Generation Infrastructure Conference Proceedings: 
30 September - 1 October 2014 International Institute of Applied Systems Analysis (IIASA) 
221 - 225, available from http://discovery.ucl.ac.uk/1469402/  
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• Pharmaceutical licensing (Europe)  
 
“The concept of adaptive licensing (AL) has met with considerable interest. Yet some remain 
skeptical about its feasibility. Others argue that the focus and name of AL should be broadened. 
Against this background of ongoing debate, we examine the environmental changes that will 
likely make adaptive pathways the preferred approach in the future. The key drivers include: 
growing patient demand for timely access to promising therapies, emerging science leading to 
fragmentation of treatment populations, rising payer influence on product accessibility, and 
pressure on pharma/investors to ensure sustainability of drug development. We also discuss a 
number of environmental changes that will enable an adaptive paradigm. A life-span approach 
to bringing innovation to patients is expected to help address the perceived access vs. evidence 
trade-off, help de-risk drug development, and lead to better outcomes for patients.” 
Hans-Georg Eichler et al. (2015): “From Adaptive Licensing to Adaptive Pathways: Delivering 
a Flexible Life-Span Approach to Bring New Drugs to Patients”, in Clinical Pharmacology and 
Therapeutics, Vol 97 No 3, March 2015, available from: 
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/ne
ws_detail_002234.jsp&mid=WC0b01ac058004d5c1  
 
• Tools for creating adaptive policies (Canada and India) 
“Experience demonstrates that policies crafted to operate within a certain range of conditions 
are often faced with unexpected challenges outside of that range. The result is that many 
policies have unintended impacts and do not accomplish their goals. Adaptive policies are 
designed to function more effectively in complex, dynamic, and uncertain conditions. Based on 
over a dozen case studies on public policies relating to agriculture and water resources 
management in Canada and India, we conclude that there are seven tools policymakers should 
follow to create adaptive policies. Adaptive policies anticipate and plan for the array of 
conditions that lie ahead: (#1) using integrated and forward-looking analysis; (#2) 
monitoring key performance indicators to trigger built-in policy adjustments; (#3) 
undertaking formal policy review and continuous learning; and (#4) using multi-stakeholder 
deliberation. But not all situations can be anticipated. Unknown unknowns and deep 
uncertainty will always be part of policymaking. Adaptive policies are able to navigate toward 
successful outcomes in settings that cannot be anticipated in advance. This can be done by 
working in concert with certain characteristics of complex adaptive systems and thereby 
facilitating autonomous actions among stakeholders on the ground. To a degree, adaptive 
policy tools #3 and #4 can be used toward this purpose, but most directly, such autonomous 
tools include: (#5) enabling self-organization and social networking; (#6) decentralizing 
decision-making to the lowest and most effective jurisdictional level; and (#7) promoting 
variation in policy responses. This paper elaborates on these seven tools as a pragmatic guide 
for policymakers who find themselves working in highly complex, dynamic, and uncertain 
settings.” 
Darren Swanson et al. (2010): “Seven tools for creating adaptive policies” in Technological 
Forecasting & Social Change Volume 77, Issue 6, July 2010, 924–939, available from 
http://www.sciencedirect.com/science/article/pii/S0040162510000727  
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• Addressing deep uncertainty using adaptive policies 
 
“...policy failures often follow from a failure to take uncertainties into account in making policy, 
and suggest that taking into account uncertainty can be essential for successful long-term 
policymaking. It is clear that uncertainty is at the heart of the very nature of long-term 
policymaking. In long-term policymaking, decision makers must make decisions about the 
future. The future is impossible to predict. But, that is no reason to throw up one's hands and 
ignore uncertainty. Quite the opposite. [...] New approaches to policymaking under conditions 
of deep uncertainty are needed—approaches that protect against and/or prepare for 
unforeseeable developments. [...]. A policy that can adapt to changing conditions is well 
suited to situations involving deep uncertainty. An adaptive policy is aware of the multiplicity 
of plausible futures that lie ahead, is designed to be changed over time as new information 
becomes available, and leverages autonomous response to surprise. The adaptive policy 
approach makes adaptation explicit at the outset of policy formulation. Thus, the inevitable 
policy changes become part of a larger, recognized process and are not forced to be made 
repeatedly on an ad-hoc basis. Under this approach, significant changes in the system would 
be based on an analytic and deliberative effort that first clarifies system goals, and then 
identifies policies designed to achieve those goals and ways of modifying those policies as 
conditions change. Within the adaptive policy framework, individual actors would carry out 
their activities as they would under normal policy conditions. But policymakers and 
stakeholders, through monitoring and corrective actions, would try to keep the system headed 
toward the original goals....” 
Warren E. Walker et al. (2010): “Addressing deep uncertainty using adaptive policies: 
Introduction to section 2” in Technological Forecasting & Social Change Volume 77, Issue 6, 
July 2010, 917–92, available from 
http://www.sciencedirect.com/science/article/pii/S0040162510000715  
 
• Law keeping pace with change 
“The consequence of this growing gap between the pace of technology and law is increasingly 
outdated and ineffective legal structures, institutions and processes to regulate emerging 
technologies. The two basic options for addressing this problem are (i) to slow or stop the pace 
of scientific progress; or (ii) to improve the capacity of the legal system to adapt to rapidly 
evolving technologies (even if this means departing from traditional forms of legal regulation 
into broader forms of governance, as discussed below).” 
Gary E. Marchant, Braden R. Allenby, Joseph R. Herkert (eds.) (2011), The Growing Gap 
Between Emerging Technologies and Legal-Ethical Oversight: The Pacing Problem (Springer), 
chapter 2, 19. 
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• OECD recommendations for ex-post Regulatory Impact Assessment and evaluation through 
the policy cycle 
The OECD provides recommendations for improving the impact, performance and efficiency 
of government interventions.  
OECD recommendations on Regulatory Policy and Governance (2012): Comprehensive policy 
cycle in which regulations are designed, assessed and evaluated ex-ante and ex-post, revised 
and enforced at all levels of government, supported by appropriate institutions 
http://www.oecd.org/gov/regulatory-policy/2012-recommendation.htm  
OECD Regulatory Policy Outlook (2015): Recommendations for evidence-based policymaking 
includes the use of Regulatory Impact Assessment and closing the regulatory governance 
cycle through systematic ex-post evaluation. http://www.keepeek.com/Digital-Asset-
Management/oecd/governance/oecd-regulatory-policy-outlook-2015_9789264238770-
en#page2  
 
• European Union “REFIT” program as part of “Better Regulation”  
As part of its “Better regulation” initiative, http://ec.europa.eu/smart-
regulation/index_en.htm , the European Commission has undertaken efforts to review the 
“fitness” of existing regulatory policies over time, called “REFIT”: 
REFIT Regulatory Fitness and Performance (REFIT): results and next steps” COM(2013)685 
http://ec.europa.eu/smart-regulation/docs/20131002-refit-annex_en.pdf  
“Better Regulation for Better Results – An EU Agenda” COM(2015)21 
http://ec.europa.eu/smart-regulation/better_regulation/key_docs_en.htm  
Example: evaluation and fitness check of the EC regulation of Pollutant Release and Transfer 
Register (E-PRTR) 
http://ec.europa.eu/smart-regulation/roadmaps/docs/2016_env_062_e-prtr_en.pdf  
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